Financial Architects (New Jersey)’s Pacira BioSciences PCRX Stock Holding History

Financial Architects (New Jersey)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-989	Closed	-$38K	–	1396
2019 Q1	$38K	Sell	989 -141	-12%	-$5.5K	0.01%	690
2018 Q4	$49K	Sell	1,130 -310	-22%	-$14.5K	0.01%	549
2018 Q3	$71K	Sell	1,440 -282	-16%	-$12.2K	0.01%	543
2018 Q2	$55K	Buy	+1,722	New	+$59.5K	0.01%	542

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Financial Architects (New Jersey)'s PCRX Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Pacira BioSciences (PCRX) in Q2 2019, closing a stake of 989 shares — an estimated $38K sold.

Financial Architects (New Jersey) first reported a position in PCRX in Q2 2018 and held it in 4 quarters. The position peaked at $71K in Q3 2018. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Pacira BioSciences position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 989 Pacira BioSciences shares in Q2 2019, an estimated $38K.
Financial Architects (New Jersey) first reported a position in Pacira BioSciences in Q2 2018 and held it in 4 quarters.
Financial Architects (New Jersey)'s Pacira BioSciences position peaked at $71K in Q3 2018.
218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.